Literature DB >> 26656459

Immune regulation of kidney disease in 2015: Updates on immunosuppression in kidney disease.

Hans-Joachim Anders1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26656459     DOI： 10.1038/nrneph.2015.202

Source DB:  PubMed          Journal:  Nat Rev Nephrol        ISSN： 1759-5061            Impact factor:   28.314


× No keyword cloud information.
  9 in total

1.  Rapid induction of clinical remission by low-dose interleukin-2 in a patient with refractory SLE.

Authors:  Jens Y Humrich; Caroline von Spee-Mayer; Elise Siegert; Tobias Alexander; Falk Hiepe; Andreas Radbruch; Gerd-Rüdiger Burmester; Gabriela Riemekasten
Journal:  Ann Rheum Dis       Date:  2015-01-21       Impact factor: 19.103

Review 2.  The genetics and immunobiology of IgA nephropathy.

Authors:  Krzysztof Kiryluk; Jan Novak
Journal:  J Clin Invest       Date:  2014-06-02       Impact factor: 14.808

Review 3.  The promise of low-dose interleukin-2 therapy for autoimmune and inflammatory diseases.

Authors:  David Klatzmann; Abul K Abbas
Journal:  Nat Rev Immunol       Date:  2015-04-17       Impact factor: 53.106

4.  Genomic responses in mouse models greatly mimic human inflammatory diseases.

Authors:  Keizo Takao; Tsuyoshi Miyakawa
Journal:  Proc Natl Acad Sci U S A       Date:  2014-08-04       Impact factor: 11.205

5.  Low-dose interleukin-2 selectively corrects regulatory T cell defects in patients with systemic lupus erythematosus.

Authors:  Caroline von Spee-Mayer; Elise Siegert; Dimas Abdirama; Angelika Rose; Anika Klaus; Tobias Alexander; Philipp Enghard; Birgit Sawitzki; Falk Hiepe; Andreas Radbruch; Gerd-Rüdiger Burmester; Gabriela Riemekasten; Jens Y Humrich
Journal:  Ann Rheum Dis       Date:  2015-08-31       Impact factor: 19.103

6.  Genomic responses in mouse models poorly mimic human inflammatory diseases.

Authors:  Junhee Seok; H Shaw Warren; Alex G Cuenca; Michael N Mindrinos; Henry V Baker; Weihong Xu; Daniel R Richards; Grace P McDonald-Smith; Hong Gao; Laura Hennessy; Celeste C Finnerty; Cecilia M López; Shari Honari; Ernest E Moore; Joseph P Minei; Joseph Cuschieri; Paul E Bankey; Jeffrey L Johnson; Jason Sperry; Avery B Nathens; Timothy R Billiar; Michael A West; Marc G Jeschke; Matthew B Klein; Richard L Gamelli; Nicole S Gibran; Bernard H Brownstein; Carol Miller-Graziano; Steve E Calvano; Philip H Mason; J Perren Cobb; Laurence G Rahme; Stephen F Lowry; Ronald V Maier; Lyle L Moldawer; David N Herndon; Ronald W Davis; Wenzhong Xiao; Ronald G Tompkins
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-11       Impact factor: 11.205

Review 7.  Immunosuppressive agents for treating IgA nephropathy.

Authors:  Mariacristina Vecchio; Bibiana Bonerba; Suetonia C Palmer; Jonathan C Craig; Marinella Ruospo; Joshua A Samuels; Donald A Molony; Francesco Paolo Schena; Giovanni F M Strippoli
Journal:  Cochrane Database Syst Rev       Date:  2015-08-03

8.  Intensive Supportive Care plus Immunosuppression in IgA Nephropathy.

Authors:  Thomas Rauen; Frank Eitner; Christina Fitzner; Claudia Sommerer; Martin Zeier; Britta Otte; Ulf Panzer; Harm Peters; Urs Benck; Peter R Mertens; Uwe Kuhlmann; Oliver Witzke; Oliver Gross; Volker Vielhauer; Johannes F E Mann; Ralf-Dieter Hilgers; Jürgen Floege
Journal:  N Engl J Med       Date:  2015-12-03       Impact factor: 91.245

Review 9.  The immune system and kidney disease: basic concepts and clinical implications.

Authors:  Christian Kurts; Ulf Panzer; Hans-Joachim Anders; Andrew J Rees
Journal:  Nat Rev Immunol       Date:  2013-09-16       Impact factor: 53.106
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.